medigraphic.com
ISSN 1405-8871 (Print)

2021, Number 3

<< Back Next >>

Aten Fam 2021; 28 (3)

Obesity in Patients with covid-19 in a Family Medicine Unit

Argüello GAJ

Language: Spanish
References: 15
Page: 213-216
PDF size: 253.58 Kb.


ABSTRACT

Objectives: to identify the prevalence of obesity in patients diagnosed with covid-19, as well as other comorbidities. Methods: cross-sectional study, simple randomized sampling was performed, files of adults, aged eighteen years or older, were reviewed, with a diagnosis of covid-19 confirmed by RT-PCR for SARS-CoV-2, attending the Family Medicine Unit (UMF) No. 186 of the Mexican Institute of Social Security (IMSS) of the State of Mexico, notified to the Online Notification System for the Epidemiological Surveillance of Influenza (SINOLAVE), from March 25, 2020 to July 3, 2020. Age, sex, body MASS index (BMI), type 2 diabetes mellitus history, hypertension and smoking were recorded, and descriptive statistics were used for variables of interest. Results: 37 files were identified, 54.05% men, 45.94% women, average age 43.1 years; 51.4% were overweight, 35.1%, obese, average BMI 28.9; 37.8% showed a history of smoking, 27%, hypertension and 16.2%, diabetes mellitus. Conclusions: there was a high prevalence of overweight and obesity (86.5%), the main comorbidity was smoking, followed by hypertension.


REFERENCES

  1. European Centre for Disease Prevention and Control (ECDC). Rapid Risk Assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, Wuhan, China; first update China 17 Jan 2020.pdf [Internet]. [Citado 2020 Ene 22]. Disponible en: http://ecdc.europa.eu/sites/default/ files/documents/Risk%20assessment%20 %20 pneumonia%20Wuhan%20China%2017%20 Jan%202020.pdf

  2. COVID-19: cronología de la actuación de la OMS [Internet]. [Citado 2020 Ene 22]. Disponible en: https://www.who.int/es/news-room/detail/27- 04-2020-who-timeline---covid-19

  3. Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, una emergencia de salud pública mundial. Revista Clínica Española, 2021;221(1)55-61.

  4. Yang J, Zheng Y. Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;(94):91‐5.

  5. Accinelli RA, Xu CM, Wang JD, Yachachin- Chávez JM, Cáceres-Pizarro JA, Tafur-Bances KB, et al. COVID-19: La pandemia por el nuevo virus SARS-CoV-2. Rev Peru Med Exp Salud Publica. 2020;37(2):302-11.

  6. Nueva revisión rápida sobre la cuarentena. [Internet]. [Citado 2020 Ene 22]. Disponible en: https://es.cochrane.org/es/news

  7. Encuesta Nacional de Salud y Nutrición (ENSANUT) 2018[Internet]. [Citado 2020 Ene 22]. Disponible en: https://ensanut.insp.mx/encuestas/ ensanut2018/doctos/informes/ensanut_2018_ presentacion_resultados.pdf

  8. Zhang F, Xiong Y, Wei Y, Hu Y, Wang F, Li G, et al. Obesity predisposes to the risk of higher mortality in young COVID-19 patients. J Med Virol. 2020;92 2536-42.

  9. Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation [published online ahead of print, 2020 Apr 9]. Obesity a Research Journal. 2020;28(7):1195-99.

  10. Rico-Fontalvo JE, Daza-Arnedo R, Pájaro-Galvis N, Leal-Martínez V, Abuabara-Franco E, Saenz- López J, Tatis-Villamizar k, Uparella-Gulfo I. Obesidad y Covid-19. Archivos de Medicina 2020;16(4):1-5.

  11. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davison KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID- 19 in the New York City Area. JAMA. 2020; 323: (20) 2052-2059.

  12. Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147.

  13. Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941.

  14. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

  15. Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID- 19? A meta-analysis Diabetes Metab Syndr. 2020;14(4):535‐45.




2020     |     www.medigraphic.com